A new Michigan Medicine study marks a major step in HIV prevention for young adults. PrEP prescriptions have surged among 18- to 25-year-olds, cutting HIV risk by 99%. Yet many don’t stay on the medication long-term. Led by Dr. Nina Hill of the Institute for Healthcare Policy and Innovation, the research shows how awareness and access are key to reaching this high-risk group. Listen to the full episode here.
